Please login to the form below

Not currently logged in
Email:
Password:

settlements

This page shows the latest settlements news and features for those working in and with pharma, biotech and healthcare.

Settlement clears path for Biogen, Samsung’s Humira biosimilar

Settlement clears path for Biogen, Samsung’s Humira biosimilar

Settlement clears path for Biogen, Samsung’ s Humira biosimilar. Agreement could see Europe access Imraldi as early as October this year. ... The Samsung Bioepis settlement reflects the strength and breadth of AbbVie's intellectual property, ”said

Latest news

More from news
Approximately 4 fully matching, plus 220 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Patent settlement, non-exclusive licence. 200. Mallinckrodt/Baxter International. RECOTHROM® Thrombin topical and PREVELEAK® Surgical Sealant to control bleeding in surgery. ... Teva/Alder Biopharmaceuticals patent settlement. We have featured Teva in

  • Risky business for pharma Risky business for pharma

    Between 1991 and 2015, 373 settlements totaling $35.7bn were reached between the US federal and state governments and pharmaceutical manufacturers.

  • Deal Watch - May 2017 Deal Watch - May 2017

    The legal case went on for another eight months until this month when Abbott and Alere announced a settlement where Abbott will pay $5bn for Alere, $0.5bn (9%) less than ... 710 (upfront 310). Alere (US). Abbott (US). Acquisition settlement. Reduction in

  • Stress testing for the perfect compliance storm Stress testing for the perfect compliance storm

    Yet the industry often hits the headlines for all the wrong reasons, with regulators imposing multibillion dollar settlements for compliance failings including corruption and bribery.

  • Deal Watch January 2017 Deal Watch January 2017

    With an immediate initial payment of $625m, the settlement includes a royalty of 6.5% (due from Jan 1 2017 to Dec 31 2023) and a lower royalty of 2.5% ... In a similar vein, Forward Pharma and Biogen also reached a settlement agreement over the Tecfidera

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics